News
News
- FDA approves Enjaymo™ (sutimlimab-jome), first treatment for use in patients with cold agglutinin disease
02/04/2022 / 23:00 - GlobeNewswire - Daniels Fund gives $60.5 million in grants and scholarships in 2021
02/02/2022 / 16:34 - GlobeNewswire - Daxor Corporation Commences Trading on The NASDAQ Capital Market
02/02/2022 / 14:00 - GlobeNewswire - Fantasy 360 Announces Name Change to XR Immersive Tech Inc.
02/01/2022 / 19:00 - GlobeNewswire - Laser Scanning Cargo Wrapped in Black Plastic is Now Obsolete
02/01/2022 / 16:00 - GlobeNewswire - Positive Topline Phase 3 MAESTRO-NAFLD-1 Data Demonstrate Resmetirom was Safe, Well-Tolerated and Provided Statistically Significant Improvements in Key Measures of Liver and Cardiovascular Health
01/31/2022 / 13:00 - GlobeNewswire - Synaptics Delivers First True Wireless Docking Experience
01/26/2022 / 14:00 - GlobeNewswire - Wendover Housing Partners Now Accepting Applications for Residents at Monroe Landings in Sanford, FL
01/25/2022 / 15:00 - GlobeNewswire - OTC Markets Group Announces Quarterly Index Performance and Rebalancing
01/25/2022 / 13:00 - GlobeNewswire - CHD Points Out Potential Human Health Risks From 5G Rollout
01/24/2022 / 15:29 - GlobeNewswire
Real-time